1. Home
  2. ALUR vs ICU Comparison

ALUR vs ICU Comparison

Compare ALUR & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.48

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$2.40

Market Cap

15.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALUR
ICU
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
15.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALUR
ICU
Price
$1.48
$2.40
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.25
N/A
AVG Volume (30 Days)
109.6K
141.1K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,208,000.00
$881,000.00
Revenue This Year
N/A
$691.85
Revenue Next Year
$15.47
$64.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1195.59
52 Week Low
$1.02
$2.20
52 Week High
$7.40
$30.70

Technical Indicators

Market Signals
Indicator
ALUR
ICU
Relative Strength Index (RSI) 46.78 64.88
Support Level $1.28 $2.37
Resistance Level $1.57 $2.71
Average True Range (ATR) 0.16 0.23
MACD -0.03 -0.05
Stochastic Oscillator 32.31 24.28

Price Performance

Historical Comparison
ALUR
ICU

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: